These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selecting candidate antigens for malaria vaccines. Kidson C; Saul A; Schofield L; Upcroft J; Don M; Read D; Myler P; Castelino D; Chiu S; Ingram L Asian Pac J Allergy Immunol; 1984 Dec; 2(2):325-8. PubMed ID: 6085274 [No Abstract] [Full Text] [Related]
3. The comparative immunobiology of Plasmodium: model systems and new technologies in malaria vaccine research. Mitchell GH Prog Vet Microbiol Immunol; 1987; 3():112-38. PubMed ID: 3078831 [No Abstract] [Full Text] [Related]
4. Limiting dilution analysis of antigen-specific CD4+ T-cell responses in mice. Seixas E; Langhorne J; Quin S Methods Mol Med; 2002; 72():385-99. PubMed ID: 12125134 [No Abstract] [Full Text] [Related]
5. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria. Rainczuk A; Scorza T; Spithill TW; Smooker PM Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453 [TBL] [Abstract][Full Text] [Related]
6. Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area. Bejon P; Kai OK; Mwacharo J; Keating S; Lang T; Gilbert SC; Peshu N; Marsh K; Hill AV Eur J Immunol; 2006 Aug; 36(8):2264-72. PubMed ID: 16856208 [TBL] [Abstract][Full Text] [Related]
7. [Vaccines blocking transmission]. Sauerwein R Med Trop (Mars); 1995; 55(4 Suppl):118. PubMed ID: 8649254 [No Abstract] [Full Text] [Related]
8. [Malaria vaccines: prospects and reality]. Rogier C; Orlandi-Pradines E; Fusaï T; Pradines B; Briolant S; Almeras L Med Mal Infect; 2006 Aug; 36(8):414-22. PubMed ID: 16949781 [TBL] [Abstract][Full Text] [Related]
10. Malaria vaccines: if at first you don't succeed.. Tongren JE; Zavala F; Roos DS; Riley EM Trends Parasitol; 2004 Dec; 20(12):604-10. PubMed ID: 15522671 [TBL] [Abstract][Full Text] [Related]
11. Apical membrane antigen 1: a malaria vaccine candidate in review. Remarque EJ; Faber BW; Kocken CH; Thomas AW Trends Parasitol; 2008 Feb; 24(2):74-84. PubMed ID: 18226584 [TBL] [Abstract][Full Text] [Related]
12. Immunoprophylaxis of malaria: characterization of a protective surface antigen. Nussenzweig RS; Nussenzweig V Harvey Lect; 1982-1983; 78():59-85. PubMed ID: 6151556 [No Abstract] [Full Text] [Related]
13. Vaccine development. Which way for malaria? Cox FE Nature; 1988 Feb; 331(6156):486-7. PubMed ID: 3124000 [No Abstract] [Full Text] [Related]
14. Parasitology. Malaria--from infants to genomics to vaccines. Long CA; Hoffman SL Science; 2002 Jul; 297(5580):345-7. PubMed ID: 12130768 [No Abstract] [Full Text] [Related]
15. Phosphatidylcholine liposomes as effective adjuvant for vaccination of mice against Plasmodium yoelii. Vinayak VK; Sharma R Indian J Med Res; 1986 Jul; 84():32-8. PubMed ID: 3770834 [No Abstract] [Full Text] [Related]
16. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge. Wang L; Goschnick MW; Coppel RL Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527 [TBL] [Abstract][Full Text] [Related]